Haematological malignancies: at the forefront of immunotherapeutic innovation
2015
The recent successes of cancer immunotherapies have stimulated interest in the potential widespread application of these approaches; haematological malignancies have provided both initial proofs of concept and an informative testing ground for various immune-based therapeutics. The immune-cell origin of many of the blood malignancies provides a unique opportunity both to understand the mechanisms of cancer immune responsiveness and immune evasion, and to exploit these mechanisms for therapeutic purposes.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
216
References
55
Citations
NaN
KQI